Literature DB >> 12202908

Hypoxia and persistent sodium current.

Anna K M Hammarström1, Peter W Gage.   

Abstract

During prolonged depolarization of excitable cells, some voltage-activated, tetrodotoxin-sensitive sodium channels are resistant to inactivation and can continue to open for long periods of time, generating a "persistent" sodium current ( I(NaP)). The amplitude of I(NaP) is small [generally less than 1% of the peak amplitude of the transient sodium current ( I(NaT))], activates at potentials close to the resting membrane potential, and is more sensitive to Na channel blocking drugs than I(NaT). It is thought that persistent Na channels are generated by a change in gating of transient Na channels, possibly because of a change in phosphorylation or protein structure, e.g. loss of the inactivation gate. Drugs that block Na channels can prevent the increase in [Ca(2+)](i) in cardiac cells during hypoxia. Hypoxia increases the amplitude of I(NaP). Paradoxically, NO causes a similar increase in I(NaP) and the effects of both can be inhibited by reducing agents such as dithiothreitol and reduced glutathione. It is proposed that an increased inflow of Na(+) during hypoxia increases [Na(+)](i), which in turn reverses the Na/Ca exchanger so that [Ca(2+)](i) rises. An increase in I(NaP) and [Ca(2+)](i) could cause arrhythmias and irreversible cell damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12202908     DOI: 10.1007/s00249-002-0218-2

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  32 in total

1.  Pre- and post-inspiratory neurons change their firing properties in female rats exposed to chronic intermittent hypoxia.

Authors:  George M P R Souza; William H Barnett; Mateus R Amorim; Ludmila Lima-Silveira; Davi J A Moraes; Yaroslav I Molkov; Benedito H Machado
Journal:  Neuroscience       Date:  2019-03-28       Impact factor: 3.590

Review 2.  Ion channels as drug targets in central nervous system disorders.

Authors:  A M Waszkielewicz; A Gunia; N Szkaradek; K Słoczyńska; S Krupińska; H Marona
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

3.  Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current.

Authors:  S Weiss; D Benoist; E White; W Teng; D A Saint
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 4.  Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations.

Authors:  Daniela Pietrobon; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 5.  Hypoxia. 4. Hypoxia and ion channel function.

Authors:  Larissa A Shimoda; Jan Polak
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-22       Impact factor: 4.249

Review 6.  Pathophysiology of the cardiac late Na current and its potential as a drug target.

Authors:  Jonathan D Moreno; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2011-12-16       Impact factor: 5.000

7.  R 56865 exerts cardioprotective properties independent of the intracellular Na(+)-overload in the guinea pig heart.

Authors:  Matthias Hartmann; Ulrich K M Decking
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-02       Impact factor: 3.000

8.  Tolterodine reduces veratridine-augmented late INa, reverse-INCX and early afterdepolarizations in isolated rabbit ventricular myocytes.

Authors:  Chao Wang; Lei-Lei Wang; Chi Zhang; Zhen-Zhen Cao; An-Tao Luo; Pei-Hua Zhang; Xin-Rong Fan; Ji-Hua Ma
Journal:  Acta Pharmacol Sin       Date:  2016-08-29       Impact factor: 6.150

9.  Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters.

Authors:  Ying-Jian Liang; Juan Zhen; Nianhang Chen; Maarten E A Reith
Journal:  J Neurochem       Date:  2009-03-11       Impact factor: 5.372

Review 10.  The cardiac persistent sodium current: an appealing therapeutic target?

Authors:  D A Saint
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.